These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 12717976)

  • 1. [Quinolone].
    Sato K; Tanaka M
    Nihon Rinsho; 2003 Mar; 61 Suppl 3():227-33. PubMed ID: 12717976
    [No Abstract]   [Full Text] [Related]  

  • 2. Mechanisms of quinolone action and microbial response.
    Hawkey PM
    J Antimicrob Chemother; 2003 May; 51 Suppl 1():29-35. PubMed ID: 12702701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular mechanisms of fluoroquinolone resistance.
    Chen FJ; Lo HJ
    J Microbiol Immunol Infect; 2003 Mar; 36(1):1-9. PubMed ID: 12741725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Investigating the fluoroquinolone molecular resistant mechanism of Stenotrophomonas maltophilia].
    Tao CM; Lü XJ; Li P
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Mar; 37(2):266-9. PubMed ID: 16608091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quinolone resistance mechanisms in pneumococci.
    Eliopoulos GM
    Clin Infect Dis; 2004 May; 38 Suppl 4():S350-6. PubMed ID: 15127369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Quinolone].
    Niki Y; Kobashi Y
    Nihon Rinsho; 2003 Feb; 61 Suppl 2():750-5. PubMed ID: 12722311
    [No Abstract]   [Full Text] [Related]  

  • 7. Alterations in the GyrA and GyrB subunits of topoisomerase II and the ParC and ParE subunits of topoisomerase IV in ciprofloxacin-resistant clinical isolates of Pseudomonas aeruginosa.
    Lee JK; Lee YS; Park YK; Kim BS
    Int J Antimicrob Agents; 2005 Apr; 25(4):290-5. PubMed ID: 15784307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased antibacterial activity of DW286, a novel fluoronaphthyridone antibiotic, against Staphylococcus aureus strains with defined mutations in DNA gyrase and topoisomerase IV.
    Yun HJ; Min YH; Jo YW; Shim MJ; Choi EC
    Int J Antimicrob Agents; 2005 Apr; 25(4):334-7. PubMed ID: 15784314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations in the GyrA subunit of DNA gyrase and the ParC subunit of topoisomerase IV in clinical strains of fluoroquinolone-resistant Shigella in Anhui, China.
    Hu LF; Li JB; Ye Y; Li X
    J Microbiol; 2007 Apr; 45(2):168-70. PubMed ID: 17483803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An unusually high level of quinolone resistance associated with type II topoisomerase mutations in quinolone resistance-determining regions of Aeromonas caviae isolated from diarrhoeal patients.
    Sinha S; Chattopadhyay S; Bhattacharya SK; Nair GB; Ramamurthy T
    Res Microbiol; 2004 Dec; 155(10):827-9. PubMed ID: 15567276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluoroquinolone resistance and gyrA and parC mutations of Escherichia coli isolated from chicken.
    Lee YJ; Cho JK; Kim KS; Tak RB; Kim AR; Kim JW; Im SK; Kim BH
    J Microbiol; 2005 Oct; 43(5):391-7. PubMed ID: 16273029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-level resistance to fluoroquinolones linked to mutations in gyrA, parC, and parE in Salmonella enterica serovar Schwarzengrund isolates from humans in Taiwan.
    Baucheron S; Chaslus-Dancla E; Cloeckaert A; Chiu CH; Butaye P
    Antimicrob Agents Chemother; 2005 Feb; 49(2):862-3. PubMed ID: 15673791
    [No Abstract]   [Full Text] [Related]  

  • 13. Resistance of different Chlamydia-like organisms to quinolones and mutations in the quinoline resistance-determining region of the DNA gyrase A- and topoisomerase-encoding genes.
    Casson N; Greub G
    Int J Antimicrob Agents; 2006 Jun; 27(6):541-4. PubMed ID: 16697560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction of the fitness burden of quinolone resistance in Pseudomonas aeruginosa.
    Kugelberg E; Löfmark S; Wretlind B; Andersson DI
    J Antimicrob Chemother; 2005 Jan; 55(1):22-30. PubMed ID: 15574475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluoroquinolone resistance in Streptococcus pyogenes.
    Richter SS; Diekema DJ; Heilmann KP; Almer LS; Shortridge VD; Zeitler R; Flamm RK; Doern GV
    Clin Infect Dis; 2003 Feb; 36(3):380-3. PubMed ID: 12539083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An extended PCR-RFLP assay for detection of parC, parE and gyrA mutations in fluoroquinolone-resistant Streptococcus pneumoniae.
    Alonso R; Galimand M; Courvalin P
    J Antimicrob Chemother; 2004 Apr; 53(4):682-3. PubMed ID: 15014061
    [No Abstract]   [Full Text] [Related]  

  • 17. High-level fluoroquinolone resistance in a clinical Streptoccoccus pyogenes isolate in Germany.
    Reinert RR; Lütticken R; Al-Lahham A
    Clin Microbiol Infect; 2004 Jul; 10(7):659-62. PubMed ID: 15214881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends in the rates of resistance of Ureaplasma urealyticum to antibiotics and identification of the mutation site in the quinolone resistance-determining region in Chinese patients.
    Xie X; Zhang J
    FEMS Microbiol Lett; 2006 Jun; 259(2):181-6. PubMed ID: 16734777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study of isolation of fluoroquinolone-resistant Ureaplasma urealyticum and identification of mutant sites.
    Zhang W; Wu Y; Yin W; Yu M
    Chin Med J (Engl); 2002 Oct; 115(10):1573-5. PubMed ID: 12490114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of resistance to quinolones: target alterations, decreased accumulation and DNA gyrase protection.
    Ruiz J
    J Antimicrob Chemother; 2003 May; 51(5):1109-17. PubMed ID: 12697644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.